Growth Hormone Disorder: Clinical Trials

3 trials for Growth Hormone Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Growth Hormone Disorder: new trials by email Literature Review of Growth Hormone Disorder trials Research Report on Growth Hormone Disorder

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
somapacitan, Norditropin® FlexPro® pen - Growth Hormone Disorder, Growth Hormone Deficiency in Children
Phase 2CompletedNovo Nordisk A/S762016-03-312026-01-16
A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone
NNC126-0083, somatropin - Growth Hormone Disorder, Growth Hormone Deficiency in Children
Phase 2CompletedNovo Nordisk A/S312009-08-012017-02-08
Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083
NNC126-0083, placebo - Growth Hormone Disorder, Adult Growth Hormone Deficiency
Phase 2CompletedNovo Nordisk A/S332008-07-012017-02-08

Narrower conditions

Dwarfism, Pituitary (1)

Broader conditions

Bone Diseases (1)  ·  Bone Diseases, Developmental (1)  ·  Bone Diseases, Endocrine (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dwarfism (1)  ·  Endocrine System Diseases (1)  ·  Hypopituitarism (1)  ·  Hypothalamic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Pituitary Diseases (1)

Interventions

NNC126-0083 (2)  ·  Human Growth Hormone (1)  ·  NNC0195-0092 (1)  ·  somapacitan (1)

Sponsors

Novo Nordisk A/S (3)

Countries

Belgium (2)  ·  Denmark (2)  ·  France (2)  ·  Israel (2)  ·  Slovenia (2)  ·  Turkey (Türkiye) (2)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  India (1)  ·  Japan (1)  ·  North Macedonia (1)  ·  Spain (1)

Results publications

PMID 21177789, PMID 21724838, PMID 31917835, PMID 33864240, PMID 34964458, PMID 36995872

NIH funding

2008 (2), 2015 (1)